Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Healthcare
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs
Bullboard Posts
User Avatar Image
(0)
•••
Comment by zadmanon Sep 01, 2017 1:26pm
149 Views
Post# 26648049

RE:RE:RE:RE:RE:Looks like the SP could come back down to 38

RE:RE:RE:RE:RE:Looks like the SP could come back down to 38I hope you're right about $10MM more on the top line. I'm not so bullish on topline growth from these levels although do agree we could see modest improvements tracking rig counts. What excites me more is the prospect of turning that $20MM of third party contractor revenue into actual Aveda equipment generated revenue. This will juice margins and should result in actual positive EPS! If EBITDA could trend to say $8MM+ per quarter - $32MM annualized, a valuation case for sub $2/share isn't all that much of a stretch. Lets all keep in mind Aveda is doing this with industry conditions in the tank. What if we ever flipped into a high tide floats all boats situation. Becomes an exciting prospect. I'm curious what Ronnie was referring to in that video about acquisition opportunities both within and outside their industry (think I heard him say that). Not sure what to think about that..... zad
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities